APLM - Apollomics Inc.

QQQ $ 454.82 $ 9.16 (2.02 %)

DIA $ 398.57 $ 1.02 (0.26 %)

SPY $ 530.36 $ 6.28 (1.19 %)

TLT $ 91.26 $ 0.68 (0.73 %)

GLD $ 225.37 $ 2.55 (1.18 %)

Previous Close

$ 0.241

Open

$ 0.25

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.24 - $ 0.25

52 Week Range

$ 0.23 - $ 6.20

Volume

736,608

Average Volume

Market Cap

21.57M

Beta (5Y Monthly)

$ 0.86

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Apollomics Reports Vebreltinib Data At The...
06/04/2024 12:23:32

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company ...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
05/29/2024 16:31:13

Apollomics Announces ~$6M Private Placemen...
05/08/2024 21:28:46

Apollomics Inc. (NASDAQ:APLM), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to addre...

HC Wainwright & Co. Maintains Buy on Apoll...
05/08/2024 19:12:44

HC Wainwright & Co. analyst Robert Burns maintains Apollomics (NASDAQ:APLM) with a Buy and lowers the price target from ...

Apollomics Announces Approval Of Vebreltin...
04/25/2024 12:42:24

Apollomics' partner in China, Avistone, received approval from National Medical Products Administration of China to expand ...

Apollomics Inc Files For Mixed Shelf Of Up...
04/01/2024 20:34:52

- SEC Filing

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
04/01/2024 20:31:02

EF Hutton Maintains Buy on Apollomics, Low...
04/01/2024 12:38:58

EF Hutton analyst Michael King maintains Apollomics (NASDAQ:APLM) with a Buy and lowers the price target from $11 to $6.5.

HC Wainwright & Co. Maintains Buy on Apoll...
04/01/2024 10:18:24

HC Wainwright & Co. analyst Robert Burns maintains Apollomics (NASDAQ:APLM) with a Buy and lowers the price target from ...

Apollomics Completed Patient Enrollment Fo...
03/28/2024 11:07:10

Apollomics FY EPS $(2.32) Up From $(8.44) YoY
03/28/2024 11:06:38

Apollomics (NASDAQ:APLM) reported quarterly losses of $(2.32) per share. This is a 72.51 percent increase over losses of $(8.44...

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
03/26/2024 21:32:33

Apollomics Appoints Matthew Plunkett As Ch...
03/04/2024 12:22:01

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
02/07/2024 13:06:01

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
02/06/2024 17:31:29

Apollomics Receives Nasdaq Notification Re...
01/19/2024 21:16:07

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
01/09/2024 13:06:02

$apollomics-completes-enrollment-in-phase-3-bridging-study-of-uproleselan-apl-106-added-to-a-standard-chemotherapy-regimen-in-chinese-patients-with-relapsedrefractory-acute-myeloid-leukemia$

Apollomics Completes Enrollment In Phase 3...
01/03/2024 12:14:37

Apollomics Announced The Presentation Of V...
12/04/2023 12:03:58

Why Salesforce Shares Are Trading Higher B...
11/30/2023 13:01:37

Shares of Salesforce, Inc.